SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-19-027042
Filing Date
2019-11-08
Accepted
2019-11-08 19:46:24
Documents
1
Period of Report
2019-11-06

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8068
  Complete submission text file 0000899243-19-027042.txt   10643
Mailing Address C/O THE BLACKSTONE GROUP 345 PARK AVE NEW YORK NY 10154
Business Address
SCHWARZMAN STEPHEN A (Reporting) CIK: 0001070844 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 191205390

Mailing Address 345 PARK AVENUE NEW YORK NY 10154
Business Address 345 PARK AVENUE NEW YORK NY 10154 (212) 583-5000
Blackstone Group Inc (Reporting) CIK: 0001393818 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 191205388
SIC: 6282 Investment Advice
Office of Finance

Mailing Address 345 PARK AVENUE NEW YORK NY 10154
Business Address 345 PARK AVENUE NEW YORK NY 10154 (212) 583-5000
Blackstone Group Management L.L.C. (Reporting) CIK: 0001404071 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-39114 | Film No.: 191205389

Mailing Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355
Business Address 101 LINDENWOOD DRIVE SUITE 405 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Issuer) CIK: 0001563577 (see all company filings)

IRS No.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences